[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$sgmo

Sangamo Therapeutics is expected to announce a deal for ST-920 soon, with the community buzzing about the potential partnership. New job openings signal progress, but some express concerns about management and deal delays.

About $sgmo

Sangamo Therapeutics (SGMO) is a biotechnology company focused on genomic medicine.

Engagements: XXXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Month: XXXXXXX -XX%
1-Year High: XXXXXXX on 2025-06-04
1-Year Low: XXXXX on 2025-06-14

Social Network	X
Engagements	XXXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +9%
1 Month: XXXXX +281%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-05-25

Social Network	X
Mentions	XXX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $sgmo in the last XX hours which is up XXXX% from XX in the previous XX hours Daily Average: XX
1 Week: XXX +0.78%
1 Month: XXX +568%
1-Year High: XXX on 2025-06-29
1-Year Low: XX on 2025-05-25

The most influential creators that mention $sgmo in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@BiotechAnalysst	X	XXXXX	X	XXXXX
@yusufhameed	X	XXXXX	X	XXXXX
@royal24508	X	XX	X	XXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% +2%
1-Year High: XXX% on 2025-04-29
1-Year Low: XX% on 2025-05-28

Most Supportive Themes

Fabry Deal Anticipation: (35%) Positive sentiment around potential partnerships and the upcoming Fabry deal, with anticipation of positive news.
Gene Therapy Advantages: (20%) Positive sentiment towards the company's gene therapy approach, especially in comparison to competitors.
Positive Developments: (20%) Mentions of positive developments such as new job postings and potential for future growth.

Most Critical Themes

Lack of Partnership/Management Concerns: (15%) Concerns about the lack of a partnership deal for ST-920 and the company's management decisions.
CEO Criticism/Deal Delay: (10%) Criticism of the company's CEO and the lack of a deal after a year of anticipation.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXXXX	XX%	XXXXX	XX%	XXX	X%

Total	XXXXX	XX%	XXXXX	XX%	XXX	X%

Top assets mentioned In the posts about $sgmo in the last XX hours

CRISPR Therapeutics AG (CRSP) TrumpCoin (DJT) Trump Media & Technology Group (DJT) Intellia Therapeutics, Inc (NTLA) Tesla, Inc. (TSLA) Tesla, Inc. (TSLA) BEAM (BEAM) Palantir (PLTR) Apple, Inc. (AAPL) Bitcoin Incognito (XBI)

Top topics mentioned In the posts about $sgmo in the last XX hours